EIDOS THERAPEUTICS, INC. Earnings Per Share, Basic and Diluted
EIDOS THERAPEUTICS, INC. reported Earnings Per Share, Basic and Diluted of -$0.75 per share for the 3-month period ending 2020-06-30, per its 10-Q filed 2020-08-06.
Discontinued › Income Statement › Earnings Per Share
us-gaap:EarningsPerShareBasicAndDiluted · last filed 2020-08-06
- EIDOS THERAPEUTICS, INC. earnings per share, basic and diluted for the quarter ending 2020-06-30 was -$0.75.
- EIDOS THERAPEUTICS, INC. earnings per share, basic and diluted for the quarter ending 2020-03-31 was -$0.60.
- EIDOS THERAPEUTICS, INC. earnings per share, basic and diluted for the quarter ending 2019-06-30 was -$0.39.
- EIDOS THERAPEUTICS, INC. earnings per share, basic and diluted for the quarter ending 2019-03-31 was -$0.32.
- EIDOS THERAPEUTICS, INC. earnings per share, basic and diluted for fiscal 2019 was -$1.03.
- EIDOS THERAPEUTICS, INC. earnings per share, basic and diluted for fiscal 2018 was -$1.86.
- EIDOS THERAPEUTICS, INC. earnings per share, basic and diluted for fiscal 2017 was -$3.32.
- EIDOS THERAPEUTICS, INC. earnings per share, basic and diluted for fiscal 2016 was -$0.98.
| Period end | Earnings Per Share, Basic and Diluted 3 month | Earnings Per Share, Basic and Diluted 3 month as first filed | Earnings Per Share, Basic and Diluted 6 month | Earnings Per Share, Basic and Diluted 6 month as first filed | Earnings Per Share, Basic and Diluted 9 month | Earnings Per Share, Basic and Diluted 12 month |
|---|---|---|---|---|---|---|
| 2020-06-30 | -$0.75 10-Q · filed 2020-08-06 | -$1.35 10-Q · filed 2020-08-06 | ||||
| 2020-03-31 | -$0.60 10-Q · filed 2020-05-08 | |||||
| 2019-12-31 | -$1.03 10-K · filed 2020-02-26 | |||||
| 2019-06-30 | -$0.39 10-Q · filed 2020-08-06 | -$0.71 10-Q · filed 2020-08-06 | -$0.98 derived: net income ÷ weighted average shares · filed 2020-08-06 | -$1.28 derived: net income ÷ weighted average shares · filed 2020-08-06 | ||
| 2019-03-31 | -$0.32 10-Q · filed 2020-05-08 | -$0.60 derived: net income ÷ weighted average shares · filed 2020-05-08 | -$0.89 derived: net income ÷ weighted average shares · filed 2020-05-08 | -$1.49 derived: net income ÷ weighted average shares · filed 2020-05-08 | ||
| 2018-12-31 | -$0.27 10-K · filed 2020-02-26 | -$0.57 derived: net income ÷ weighted average shares · filed 2020-02-26 | -$1.19 derived: net income ÷ weighted average shares · filed 2020-02-26 | -$1.86 10-K · filed 2020-02-26 | ||
| 2018-09-30 | -$0.30 10-K · filed 2020-02-26 | -$0.29 10-Q · filed 2018-11-06 | -$1.00 derived: net income ÷ weighted average shares · filed 2020-02-26 | -$2.28 10-Q · filed 2018-11-06 | -$2.68 derived: net income ÷ weighted average shares · filed 2020-02-26 | |
| 2018-06-30 | -$1.40 10-K · filed 2020-02-26 | -$1.38 10-Q · filed 2018-08-07 | -$3.06 10-Q · filed 2019-08-01 | -$4.41 10-Q · filed 2018-08-07 | -$4.48 derived: net income ÷ weighted average shares · filed 2020-02-26 | -$5.41 derived: net income ÷ weighted average shares · filed 2020-02-26 |
| 2018-03-31 | -$1.81 10-K · filed 2020-02-26 | -$3.16 derived: net income ÷ weighted average shares · filed 2020-02-26 | -$3.96 derived: net income ÷ weighted average shares · filed 2020-02-26 | -$4.52 derived: net income ÷ weighted average shares · filed 2020-02-26 | ||
| 2017-12-31 | -$1.32 10-K · filed 2019-04-15 | -$2.07 derived: net income ÷ weighted average shares · filed 2020-02-26 | -$2.59 derived: net income ÷ weighted average shares · filed 2020-02-26 | -$3.32 10-K · filed 2020-02-26 | ||
| 2017-09-30 | -$0.74 10-K · filed 2019-04-15 | -$1.24 derived: net income ÷ weighted average shares · filed 2019-04-15 | -$1.95 10-Q · filed 2018-11-06 | |||
| 2017-06-30 | -$0.49 10-K · filed 2019-04-15 | -$1.20 10-Q · filed 2018-08-07 | ||||
| 2017-03-31 | -$0.72 10-K · filed 2019-04-15 | |||||
| 2016-12-31 | -$0.98 10-K · filed 2019-04-15 |